Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response.
Saved in:
| Title: | Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response. |
|---|---|
| Authors: | Kleczko EK; Departments of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Le AT; Departments of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Hinz TK; Departments of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; Eastern Colorado VA Healthcare System, Rocky Mountain Regional VA Medical Center, Aurora, CO, USA., Nguyen TT; Departments of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Navarro A; Departments of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Hu CJ; Departments of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Selman AM; Departments of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Clambey ET; Departments of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Merrick DT; Departments of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Lu S; Departments of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Weiser-Evans M; Departments of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Nemenoff RA; Departments of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Electronic address: Raphael.nemenoff@cuanschutz.edu., Heasley LE; Departments of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; Eastern Colorado VA Healthcare System, Rocky Mountain Regional VA Medical Center, Aurora, CO, USA. Electronic address: Lynn.heasley@cuanschutz.edu. |
| Source: | Cancer letters [Cancer Lett] 2023 Mar 01; Vol. 556, pp. 216062. Date of Electronic Publication: 2023 Jan 16. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36657561 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kleczko+EK%22">Kleczko EK</searchLink>; Departments of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Le+AT%22">Le AT</searchLink>; Departments of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Hinz+TK%22">Hinz TK</searchLink>; Departments of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; Eastern Colorado VA Healthcare System, Rocky Mountain Regional VA Medical Center, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+TT%22">Nguyen TT</searchLink>; Departments of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Navarro+A%22">Navarro A</searchLink>; Departments of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Hu+CJ%22">Hu CJ</searchLink>; Departments of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Selman+AM%22">Selman AM</searchLink>; Departments of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Clambey+ET%22">Clambey ET</searchLink>; Departments of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Merrick+DT%22">Merrick DT</searchLink>; Departments of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Lu+S%22">Lu S</searchLink>; Departments of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Weiser-Evans+M%22">Weiser-Evans M</searchLink>; Departments of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Nemenoff+RA%22">Nemenoff RA</searchLink>; Departments of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Electronic address: Raphael.nemenoff@cuanschutz.edu.<br /><searchLink fieldCode="AU" term="%22Heasley+LE%22">Heasley LE</searchLink>; Departments of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; Eastern Colorado VA Healthcare System, Rocky Mountain Regional VA Medical Center, Aurora, CO, USA. Electronic address: Lynn.heasley@cuanschutz.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227600053%22">Cancer letters</searchLink> [Cancer Lett] 2023 Mar 01; Vol. 556, pp. 216062. <i>Date of Electronic Publication: </i>2023 Jan 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ireland%22">Elsevier Science Ireland </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>7600053 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-7980 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203043835%22">03043835 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Lett <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36657561 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.canlet.2023.216062 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 216062 Titles: – TitleFull: Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kleczko EK – PersonEntity: Name: NameFull: Le AT – PersonEntity: Name: NameFull: Hinz TK – PersonEntity: Name: NameFull: Nguyen TT – PersonEntity: Name: NameFull: Navarro A – PersonEntity: Name: NameFull: Hu CJ – PersonEntity: Name: NameFull: Selman AM – PersonEntity: Name: NameFull: Clambey ET – PersonEntity: Name: NameFull: Merrick DT – PersonEntity: Name: NameFull: Lu S – PersonEntity: Name: NameFull: Weiser-Evans M – PersonEntity: Name: NameFull: Nemenoff RA – PersonEntity: Name: NameFull: Heasley LE IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2023 Mar 01 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1872-7980 Numbering: – Type: volume Value: 556 Titles: – TitleFull: Cancer letters Type: main |
| ResultId | 1 |